XCancer

First-in-Human Study of 111In-XYIMSR-01 SPECT/CT in Patients With Metastatic Clear Cell Renal Cell Carcinoma

Description:

This study is being done to determine if the investigational radiotracer called 111In-XYIMSR-01 is helpful in detecting clear cell renal cell carcinoma tissue in your body when used during a SPECT-CT Scan

Sponsor:

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase:

Phase 1

Contacts:

Jasmine Brooks

jbrook54@jhmi.edu

Yasser Ged, MBBS

yged1@jhmi.edu

410-955-8893

Government Study Link:

NCT07062549 - Click here to see study on

ClinicalTrials.gov

111In-XYIMSR-01

Isotope(s):
Target(s):
  • CAIX
Chelator: DOTA